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Abstract
Objective: To determine the common medical conditions, medications, and associated drug therapy problems in
an underserved minority population receiving medication therapy management services at a large Community Free
Clinic compared to the findings of the Minnesota Pharmaceutical Care Project.
Methods: Retrospective cohort study of a random sample of 60 minority patients referred for medication therapy
management service at a Community Free Clinic from January 2012 to January 2014. Patient data including
demographics, medication experience, past medical and medication history, medical conditions, active medications,
allergies, immunization history and drug therapy was systematically evaluated to determine the most common
conditions, and any drug therapy problems present, compared to findings of the Minnesota Pharmaceutical Care
Project . The data was analyzed using descriptive statistics.
Results: 25 (73%) patients were 51 years and older of which 73% female. The top most common medical
conditions were hypertension, Type II diabetes mellitus, and dyslipidemia. The most common medications were
antihypertensive, oral anti-diabetic and non-steroidal anti-inflammatory drugs. Needs additional drug therapy
(48.9%), Dosage too low (16.3%) and Non-adherence (11.6%) were the leading drug therapy problems identified.
Conclusion: Hypertension, type II diabetes and dyslipidemia were the leading chronic medical conditions
whereas Needs Additional Drug Therapy, Dosage Too Low and Non-Compliance were the associated most common
drug therapy problems in the minority population. These results were comparable to the findings among the general
population in the Minnesota Pharmaceutical Care Project.

Keywords: Medication therapy management; Drug therapy
problems; Underserved; Minority; Pharmacotherapy; Advanced
pharmacy practice experience; Medicare modernization act;
Affordable care act.

Abbreviations:
APPE: Advance Pharmacy Practice Experience; CMTR:
Comprehensive Medication Therapy Review; DTP: Drug Therapy
Problems; MAP: Medication Action Plan; MMA: Medicare
Modernization Act; MPCP: Minnesota Pharmaceutical Care Project;
MTM: Medication Therapy Management; PharmD: Doctor of
Pharmacy

Background
Drug-related mortality and morbidity is a major public health
concern in the U.S [1-3]. It is estimated that 100,000 deaths occur
annually due to drug-related problems; costing the taxpayers
approximately $201.4 billion in direct medical costs per year [1-4]. To
address the problems the Center of Medicare and Medicare Services
(CMS) and the Affordable Care Act, 2010, now require that Part D
sponsors and third payers provide Medication Therapy Management
J Pharma Care Health Sys
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(MTM) to the enrollees as an essential healthcare benefit [5,6]. The
Medicare Prescription Drug and Improvement, and Modernization
Act of 2003 (MMA) describes MTM as the drug therapy management
programs provided to ensure that drugs are used appropriately in
order to optimize therapeutic outcomes through improved medication
use and reduce risk of adverse events [7]. MTM services are provided
in the context of “pharmaceutical care” that was first described in 1975
for the care that a given patient requires and receives to ensure safe and
rational use of medications [8,9]. MTM is an evolving service that
encourages a collaborative approach for drug decision-making by
physicians, pharmacist, and other health care providers together with
the patient to improve health outcomes [10-12].
Medication therapy management has been shown to optimize drug
therapy, improve clinical outcomes and decrease medical costs [7-9].
For every dollar invested in providing MTM to ambulatory patients, $2
dollars can be saved by reducing the cost of hospitalization, office and
emergence care visits [2,7,9].
Several studies have published the extent of the chronic medical
conditions burden, leading drug-related problems and management in
the general population [2,3], however studies on the minority
population is lacking in literature. This study was conducted in a
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community free clinic that serves a predominantly minority
population to determine the leading medical conditions, common
medications utilized, and extent of drug therapy problems in the
underserved. The study was a collaborative effort by providers at the
clinic that included clinical pharmacists as a part of the medical team
to specifically address the management of medication-related problems
and to help improve patient outcomes served at the clinic [10-12].
The community free clinic is located in Newport News, Virginia. It
provides comprehensive medical services to the minority residents of
the City of Newport News, VA and the surrounding areas. The patients
seen at the clinic are adults aged 21 years old and above, who do not
have insurance coverage, and are of low economic status. It is staffed by
primary care and specialty providers comprising of physicians, nurse
practitioners, dentists, social workers, clinical faculty/pharmacists,
pharmacy and nursing students on clinical rotations.
As part of the experiential education and community outreach the
Hampton University School of Pharmacy, clinical faculty provide
patient-centred Medication Therapy Management services to
underserved patients at the free clinic. The clinic also serves as an
Advanced Pharmacy Practice Experience (APPE) site for Ambulatory
Care rotations for P4 students at Hampton University School of
Pharmacy, and clinical training site for nursing, nurse practitioner,
students from the Hampton University School of Nursing and other
colleges in the areas. The clinic offers and excellent opportunity for
interdisciplinary training for students and collaborative approach in
delivery of care to the underserved population in the Hampton roads
area.
Prior to January 2012, patients at the free clinic were not receiving
MTM services. Clinical faculty from Hampton University School of
Pharmacy established a practice affiliation with clinic to offer advanced
pharmacy practice experiential (APPE) education in ambulatory care
to students and provide patient-centred medication therapy
management modelled after the Minnesota Pharmaceutical Care
project [2,13-17].
Initial chart review and face-face patient interviews revealed
incomplete medication histories, lists of active medications, utilization
pattern and a need for medication reconciliation during intake and
subsequent office visits. After consultation with the clinic
administration and other health care providers the medication
reconciliation process was expanded to include offering MTM services
to all patients and especially those diagnosed with chronic conditions
and were on multiple medications. The support by the clinic for
implementing MTM was based on demonstration from literature that
these groups of patients have been shown to benefit most from MTM
services in terms of improving their economic, clinical and humanistic
outcomes [2-4,10,16].
In addition to implementing MTM, Hampton University clinical
faculty who are all Doctor of Pharmacy (PharmDs) and licensed
pharmacist by the Virginia Board of Pharmacy, were subsequently
accorded provider status to offer patient-centred MTM service as part
of collaborative care with other members of the medical team of
physicians, nurse practitioners and physician assistants [7,10,12]. To
improve the efficiency and effectiveness of delivering MTM a referral
service was created at the clinic for the primary and specialty providers
to refer patients to clinical faculty for consultation especially those that
were diagnosed with one or more chronic medical conditions and were
on multiple medications.
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The MTM services at the clinic are provided by in five-step process:
patient assessment, care plan development, follow-up evaluation and
documentation, patient counseling, and consultation with the primary
care/specialty care provider [2,18-22]. Patient assessment is done by
conducting a face-to-face interview and completing a comprehensive
medication therapy review (CMTR) on each patient by APPE students
using a Pharmacotherapy Workup® notes [2] under direct supervision
of a pharmacy practice faculty (Pharm D. and licensed pharmacist).
The assessment method allows for the identification of all potential or
actual drug therapy problems (DTPs) that may prevent the
achievement of the goals of therapy. Based on the DTPs that have been
identified individualized care plans are developed using evidencebased practice guidelines to prevent and resolve the DTPS and to help
improve patient health outcomes.
The patients are then scheduled for face-to-face counselling on the
findings of the assessment and the care plans developed from the
initial visit. During counselling each patient is provided with a
personal pharmaceutical education and medication action plan (MAP)
18 for each specific disease condition intended to improve the safety
and effectiveness of the recommended interventions. A follow-up
evaluation is then scheduled to determine whether the goals of therapy
have been achieved as per the care plan. The entire visit is documented
in an electronic medical record, Assurance [23,24].
The overall goal of the MTM service provided at the free clinic is to
improve clinical, economic and humanistic outcomes of the
underserved population by ensuring that all medications taken by the
patient are appropriately indicated, the most effective, the safest
possible, and that the patients are willing and able to take the
medications as instructed. This study utilized a patient-centred
pharmaceutical model that has was validated by the Minnesota
Pharmaceutical Care Project [2,21].

Design
This is a retrospective cohort study of a random sample of 60
minority patients that were referred for medication therapy
management services at a Community Free Clinic in the City of
Newport News, VA, from January 2012 to January 2014.
An institutional review board approval was obtained prior to the
study. To be included, the patient must have been prequalified as
uninsured, diagnosed with a chronic condition using International
Classification of Diseases -10 (ICD-10) codes, took one or more
medications, had a completed comprehensive medication therapy
review and documented in Assurance ™ electronic medical record. Of
these patients 34 met the inclusion criteria. The patient medical charts
were manually reviewed and data including demographics, medication
experience, past medical and medication history, medical conditions,
active medications, immunization history and drug therapy was
systematically evaluated to determine the most common conditions,
medications and drug therapy problems (DTPs) present. We defined
drug therapy problems as any desirable event or risk experienced by a
patient that involve or is suspected to involve drug therapy and that
inhibit or delay the achievement of goals of therapy [2,21].
Drug therapy problems are based on assessing whether all the
medications including prescription and over-the counter products are
indicated, effective, safe and that the patient was willing and able to
take the medications intended. Medication experience was defined as
the sum of all events in a patient’s lifetime that relate to drug therapy
including medication history, current medication record [2,21]. The
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results were compared to findings of the Minnesota Pharmaceutical
Care Project using descriptive statistics.

10

Preventative
(13.9%)

immunizations Hypothyroidism (12.6%)

Results

Table 2: The ten most common medical conditions.

Subjects Demographic Variables

Common medications utilized

Of the 60 patients that were randomly selected for the study 34 met
the inclusion criteria and were eligible for analysis. All patients that
were included in the analysis were minority patients that were
uninsured, underserved and receiving care at the community free
clinic. Table 1 shows the subject’s demographic information.

Table 3 shows the ranking of the mostly frequently used
medications in the study population. The top three drug classes most
frequently used by the patients at the community free clinic were antihypertensives, oral antidiabetics, Non-Steroidal Anti-Inflammatory
Drugs. These findings were similar to the Minnesota Pharmaceutical
Care Project [2,15].

Variable

Category

Frequency N=34

Age

<50 years old

9 (27%)

>50 years old

Ranking

Newport News Clinic

Minnesota
Project

25 (73%)

1

Anti-hypertensives

Oral antidiabetics

Male

9 (27%)

2

Oral anti-diabetics

Antihypertensives

Female

25 (73%)

3

Non-steroidal
inflammatory drugs

4

Immunizations

Antilipidemics

Of the 34 patients, twenty five (73%) were aged 51 years and older
and comprised of 73% female and 27% male. The higher female ratio is
comparable to the findings of the Minnesota Pharmaceutical Care
Project (58% female, 34.9% male and 7.2% unspecified) [2,15,17].

5

Antilipidemics

Non-steroidal anti-inflammatory drugs

6

Proton pump inhibitors

Nutritional supplements

7

Narcotic analgesics

Anti-asthmatic-beta adrenergics

Common medical conditions

8

Nutritional supplements

Estrogens & progestins

Table 2 shows the results of the most common medical conditions
that were found in the minority population compared to the findings
from the Minnesota Pharmaceutical care project (MPCP). The results
showed that hypertension (82.1%), diabetes mellitus (42.74%), and
dyslipidemia (36.5%) were the leading medication conditions in the
study population.

9

Anticonvulsants

Anti-infectives

10

Antidepressants

Narcotic analgesics

Gender

Table 1: Descriptive demographic information.

These findings were similar to the results of the Minnesota
Pharmaceutical Care Project (Table 2) [2,15].
Ranking

Community Free Clinic of Minnesota
Pharmaceutical
Newport News (% no. of Care Project (% no. of
patients)
patients)

1

Hypertension (82.1%)

Hypertension (55.3%)

2

Diabetes mellitus (42.74%)

Dyslipidemia (33.1%)

3

Dyslipidemia (36.5%)

Diabetes mellitus (27.6)%

4

Generalized pain (28.2%)

Arthritis (24.7%)

5

GERD (18.0%)

Osteoporosis (24.1%)

6

Obesity (17.6%)

Peptic ulcer disease (22.9%)

7

Neuropathy (15.3%)

Allergic rhinitis (19.3%)

8

Arthritis (15.2%)

Depression (16.1%)

9

Ischemic
(14.1%)

heart

disease Menopausal symptoms (15.2%)
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Pharmaceutical

Care

anti- salicylates

Table 3: The ten most frequently used medications in all patients.

Common drug therapy problems
The drug therapy problems were classified according to the seven
major categories as per the Cipolle et al [2].
Table 4 shows the frequency distribution of drug therapy problems
encountered in the study population. The most frequent DTPs per
condition were Needs additional drug therapy (48.9%), Dosage too low
(16.3%) and Non-adherence (11.6%) which is comparable to the
Minnesota Pharmaceutical Care findings [2,15].
Ranki
ng

Community Free No. of DTPs
Clinic of Newport
News

Minnesota
Pharmaceutical
Care Project

1

Needs Additional n=72 (48.9%)
Drug Therapy

Needs Additional n=1230
Drug Therapy
(30.8%)

2

Dosage Too Low

n=24 (16.3%)

Dosage Too Low

n=887
(22.2%)

3

Non-compliance

n=17 (11.6%)

Non-compliance

n=648
(16.2%)

4

Adverse
Reaction

5

Unnecessary Drug n=10 (6.8%)
Therapy

Drug n=14 (9.5%)

Adverse
Reaction

No.
DTPS

of

Drug n=553
(13.8%)

Unnecessary
Drug Therapy

n=276
(6.9%)
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Table 4: The most frequent drug therapy problems (DTPs) in all
patients.

all the three instances the findings were comparable to the Minnesota
Pharmaceutical Care Project except for a slightly higher prevalence of
heart diseases and obesity in the minority group compared to the
general population. These findings most prevalent medical conditions
and associated drug therapy problems are critical in resource planning
for delivery of medication therapy management services in a free
clinic. However, more studies are needed to evaluate the impact of the
MTM services on the economic, clinical and humanistic outcomes of
the minority patients.

Discussion

References:

The study found that hypertension, diabetes type II, and
hyperlipidemia are the three most common chronic conditions in the
underserved minority population, which is also the case in the general
population from the Minnesota pharmaceutical care Project and other
studies [2,4,15,17]. These comorbidities are known to be major risk
factors for cardiovascular diseases, the leading cause of death in the
U.S [24]. Moreover, these medical conditions were found to be
associated with the most frequent drug therapy problems in the
Minnesota Project [2]. This information is important with respect to
the chronic medical conditions that providers should target when
planning delivery of medication therapy management services. With
respect to medication utilization, antihypertensive and antidiabetic
drugs were the most commonly used in the study population. This also
corresponds to the most common medical conditions that were
identified in the study. This knowledge of the most common medical
conditions and medications in the minority population will help define
priority areas for practitioner training in disease state management.

1.

6

Different
Needed

Drug n=5 (3.4%)

Different
Needed

Drug n=225
(5.6%)

7

Dosage Too High

n=1 (0.7%)

Dosage Too High

n=176
(4.4%)

Total DTPs

N=147

Total DTPs

N=3995

The study showed needs additional drug therapy (48%) was the
leading drug therapy problem (DTP) in the target population which is
similar finding in the Minnesota Project. This category of drug therapy
problem is present when the patients has a untreated medical
conditions, needs additional medication for synergistic therapy, or
preventative therapy is indicated as per practice guidelines [2,21]. The
second most common DTP was Dosage too low (16.3%). This was
similar to the MPCP findings [2]. This could mean that the patients
were being initiated at a much lower than recommended therapeutic
doses, infrequent dosing or a short duration of therapy. The third most
common DTP was non-compliance (11.6%). This was also similar to
the MPCP findings [2]. Has been reported in literature as a problem
having a significant impact on both the clinical and economic
outcomes [2].
Most of the patients were on multiple medications. Prior to the
introduction MTM services there was no program in place that
targeted improvement of adherence. There is a bigger need in this low
socioeconomic class patient. It is imperative that these common DTPS
be addressed as a priority otherwise they will prevent achievement of
therapeutic goals leading poor health outcomes in these population of
patients.

Conclusion
The results showed that hypertension, diabetes mellitus, and
dyslipidemia were the leading chronic medical conditions in the
minority patients seen at community free clinic whereas
antihypertensive and antidiabetic drugs were the most commonly
utilized medications in the target population. Needs additional drug
therapy, Dosage too low, and Non-adherence were the leading drug
therapy problems among the minority population seen at the clinic. In
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